| Date Filed | Type | Description |
| 08/03/2023 |
4
| SOLAND DANIEL B (Director) has filed a Form 4 on DBV Technologies S.A.|
Txns:
| Bought 15,000 shares
@ $1.62, valued at
$24.3k
|
|
| 07/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/04/2022 |
4
| SOLAND DANIEL B (COO) has filed a Form 4 on IDERA PHARMACEUTICALS, INC.|
Txns:
| Granted 41,500 options to buy
@ $0.535, valued at
$22.2k
|
|
| 01/26/2022 |
4
| SOLAND DANIEL B (COO) has filed a Form 4 on IDERA PHARMACEUTICALS, INC.|
Txns:
| Granted 25,000 options to buy
@ $0.5746, valued at
$14.4k
|
|
| 10/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/12/2021 |
4
| SOLAND DANIEL B (COO) has filed a Form 4 on IDERA PHARMACEUTICALS, INC.|
Txns:
| Granted 66,500 options to buy
@ $1.11, valued at
$73.8k
|
|
| 06/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/11/2021 |
4
| SOLAND DANIEL B (Director) has filed a Form 4 on DBV Technologies S.A.|
Txns:
| Bought 6,837 warrants
@ $7.12, valued at
$48.7k
|
|
| 03/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/11/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 01/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 10/02/2020 |
4
| SOLAND DANIEL B (Director) has filed a Form 4 on KalVista Pharmaceuticals, Inc.|
Txns:
| Granted 7,000 options to buy
@ $12.88, valued at
$90.2k
|
|
| 10/02/2020 |
4
| SOLAND DANIEL B (Director) has filed a Form 4 on KalVista Pharmaceuticals, Inc.|
Txns:
| Granted 7,000 options to buy
@ $12.88, valued at
$90.2k
|
|
| 06/25/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/30/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/28/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/23/2019 |
4
| SOLAND DANIEL B (Director) has filed a Form 4 on KalVista Pharmaceuticals, Inc.|
Txns:
| Granted 14,000 options to buy
@ $26.4, valued at
$369.6k
|
|
| 04/23/2019 |
3
| SOLAND DANIEL B (Director) has filed a Form 3 on KalVista Pharmaceuticals, Inc. |
| 06/08/2018 |
4
| SOLAND DANIEL B (Director) has filed a Form 4 on ACADIA PHARMACEUTICALS INC|
Txns:
| Granted 15,000 options to buy
@ $17.52, valued at
$262.8k
|
|
| 03/02/2018 |
4
| SOLAND DANIEL B (Director) has filed a Form 4 on ACADIA PHARMACEUTICALS INC|
Txns:
| Bought 2,000 shares
@ $23.02, valued at
$46k
Bought 3,000 shares
@ $24.09, valued at
$72.3k
Bought 2,000 shares
@ $24.52, valued at
$49k
Bought 3,000 shares
@ $22.52, valued at
$67.6k
|
|
| 07/19/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/14/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/10/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/17/2015 |
4
| SOLAND DANIEL B (Director) has filed a Form 4 on ACADIA PHARMACEUTICALS INC|
Txns:
| Granted 12,500 options to buy
@ $39.06, valued at
$488.3k
|
|
| 03/24/2015 |
4
| SOLAND DANIEL B (Director) has filed a Form 4 on ACADIA PHARMACEUTICALS INC|
Txns:
| Granted options to buy
@ $34.45, valued at
$0 |
|
| 01/28/2014 |
4
| SOLAND DANIEL B (VP, COO) has filed a Form 4 on VIROPHARMA INC|
Txns:
| Unknown transaction of 153,332 shares
@ $50, valued at
$7.7M
Granted 65,818 shares
@ $0
Disposed/sold 65,818 shares
@ $0
Disposed/sold 68,824 options to buy
@ $12.83, valued at
$883k
Disposed/sold 33,439 options to buy
@ $15.24, valued at
$509.6k
Disposed/sold 40,000 options to buy
@ $13.97, valued at
$558.8k
Disposed/sold 14,999 options to buy
@ $9.96, valued at
$149.4k
Disposed/sold 74,975 options to buy
@ $9.99, valued at
$749k
Disposed/sold 67,593 options to buy
@ $13.5, valued at
$912.5k
Disposed/sold 30,304 options to buy
@ $8.86, valued at
$268.5k
Disposed/sold 62,500 options to buy
@ $11.31, valued at
$706.9k
|
|
| 01/10/2014 |
4
| SOLAND DANIEL B (VP, COO) has filed a Form 4 on VIROPHARMA INC|
Txns:
| Paid exercise price by delivering 155 shares
@ $49.8, valued at
$7.7k
Paid exercise price by delivering 2,419 shares
@ $49.8, valued at
$120.5k
Paid exercise price by delivering 1,175 shares
@ $49.8, valued at
$58.5k
Paid exercise price by delivering 558 shares
@ $49.8, valued at
$27.8k
Exercised 1,000 options to buy
@ $5.91, valued at
$5.9k
Exercised 11,412 options to buy
@ $8.86, valued at
$101.1k
Exercised 5,025 options to buy
@ $9.99, valued at
$50.2k
Exercised 1,852 options to buy
@ $13.5, valued at
$25k
|
|
| 12/31/2013 |
4
| SOLAND DANIEL B (VP, COO) has filed a Form 4 on VIROPHARMA INC|
Txns:
| Paid exercise price by delivering 1,809 shares
@ $49.86, valued at
$90.2k
Exercised 11,500 options to buy
@ $5.91, valued at
$68k
|
|
| 12/20/2013 |
4
| SOLAND DANIEL B (VP, COO) has filed a Form 4 on VIROPHARMA INC|
Txns:
| Paid exercise price by delivering 17,529 shares
@ $49.74, valued at
$871.9k
Paid exercise price by delivering 46,554 shares
@ $49.74, valued at
$2.3M
Exercised 37,500 options to buy
@ $5.91, valued at
$221.6k
Exercised 83,284 options to buy
@ $8.86, valued at
$737.9k
|
|
| 06/12/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/07/2013 |
4
| SOLAND DANIEL B (VP, COO) has filed a Form 4 on VIROPHARMA INC|
Txns:
| Granted 46,093 options to buy
@ $23.37, valued at
$1.1M
|
|
|